AstraZeneca shares rise after surprise lung disease trial win

AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…

Novo Nordisk and Pfizer executives weigh in

US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…